{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:52:04Z","timestamp":1782240724787,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104244"],"award-info":[{"award-number":["82104244"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00406-025-02036-6","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T03:19:22Z","timestamp":1749266362000},"page":"2275-2284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Causal relationship between proton pump inhibitors and dementia risk: evidence from a Mendelian randomization study"],"prefix":"10.1007","volume":"275","author":[{"given":"Mengmeng","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2352-4854","authenticated-orcid":false,"given":"Haohao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"issue":"8","key":"2036_CR1","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.arcmed.2012.11.003","volume":"43","author":"AL Sosa-Ortiz","year":"2012","unstructured":"Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ (2012) Epidemiology of dementias and alzheimer\u2019s disease. Arch Med Res 43(8):600\u2013608. https:\/\/doi.org\/10.1016\/j.arcmed.2012.11.003","journal-title":"Arch Med Res"},{"key":"2036_CR2","first-page":"56","volume-title":"Psychiatry [M]. Page seven","author":"Y Hao Wei","year":"2013","unstructured":"Hao Wei Y, Yi YH et al (2013) Psychiatry [M]. Page seven. People\u2019s Medical Publishing House, Beijing, pp 56\u201357"},{"key":"2036_CR3","volume-title":"World alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends","author":"M Prince","year":"2015","unstructured":"Prince M, Wimo A, Guerchet M, Claire Ali G, Wu Y-T, Prina M (2015) World alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer\u2019s Disease International (ADI), London"},{"issue":"5","key":"2036_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.23736\/S0026-4806.18.05705-1","volume":"109","author":"V Savarino","year":"2018","unstructured":"Savarino V, Marabotto E, Zentilin P et al (2018) The appropriate use of proton-pump inhibitors. Minerva Med 109(5):386\u2013399. https:\/\/doi.org\/10.23736\/S0026-4806.18.05705-1","journal-title":"Minerva Med"},{"issue":"2","key":"2036_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4068\/cmj.2023.59.2.115","volume":"59","author":"NMP Maideen","year":"2023","unstructured":"Maideen NMP (2023) Adverse effects associated with Long-Term use of proton pump inhibitors. Chonnam Med J 59(2):115\u2013127. https:\/\/doi.org\/10.4068\/cmj.2023.59.2.115","journal-title":"Chonnam Med J"},{"issue":"5","key":"2036_CR6","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s12325-017-0532-9","volume":"34","author":"LY Yu","year":"2017","unstructured":"Yu LY, Sun LN, Zhang XH et al (2017) A review of the novel application and potential adverse effects of proton pump inhibitors. Adv Ther 34(5):1070\u20131086. https:\/\/doi.org\/10.1007\/s12325-017-0532-9","journal-title":"Adv Ther"},{"issue":"4","key":"2036_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","volume":"73","author":"W Gomm","year":"2016","unstructured":"Gomm W, von Holt K, Thom\u00e9 F et al (2016) Association of proton pump inhibitors with risk of dementia: A pharmacoepidemiological claims data analysis. JAMA Neurol 73(4):410\u2013416. https:\/\/doi.org\/10.1001\/jamaneurol.2015.4791","journal-title":"JAMA Neurol"},{"issue":"5","key":"2036_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00406-014-0554-0","volume":"265","author":"B Haenisch","year":"2015","unstructured":"Haenisch B, von Holt K, Wiese B et al (2015) Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur Arch Psychiatry Clin Neurosci 265(5):419\u2013428. https:\/\/doi.org\/10.1007\/s00406-014-0554-0","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"12","key":"2036_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.21037\/atm.2016.06.14","volume":"4","author":"K Wijarnpreecha","year":"2016","unstructured":"Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Ungprasert P (2016) Proton pump inhibitors and risk of dementia. Ann Transl Med 4(12):240. https:\/\/doi.org\/10.21037\/atm.2016.06.14","journal-title":"Ann Transl Med"},{"issue":"2","key":"2036_CR10","doi-asserted-by":"publisher","first-page":"e0171006","DOI":"10.1371\/journal.pone.0171006","volume":"12","author":"SY Tai","year":"2017","unstructured":"Tai SY, Chien CY, Wu DC et al (2017) Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan. PLoS ONE 12(2):e0171006 Published 2017 Feb 15. https:\/\/doi.org\/10.1371\/journal.pone.0171006","journal-title":"PLoS ONE"},{"issue":"2","key":"2036_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/alz.13477","volume":"20","author":"N Pourhadi","year":"2024","unstructured":"Pourhadi N, Janbek J, Jensen-Dahm C, Gasse C, Laursen TM, Waldemar G (2024) Proton pump inhibitors and dementia: A nationwide population-based study. Alzheimers Dement 20(2):837\u2013845. https:\/\/doi.org\/10.1002\/alz.13477","journal-title":"Alzheimers Dement"},{"issue":"Suppl 4","key":"2036_CR12","first-page":"S27","volume":"36","author":"J Welu","year":"2019","unstructured":"Welu J, Metzger J, Bebensee S, Ahrendt A, Vasek M (2019) Proton pump inhibitor use and risk of dementia in the veteran population. Fed Pract 36(Suppl 4):S27\u2013S31","journal-title":"Fed Pract"},{"issue":"9","key":"2036_CR13","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1111\/jgs.14956","volume":"65","author":"FC Goldstein","year":"2017","unstructured":"Goldstein FC, Steenland K, Zhao L, Wharton W, Levey AI, Hajjar I (2017) Proton pump inhibitors and risk of mild cognitive impairment and dementia. J Am Geriatr Soc 65(9):1969\u20131974. https:\/\/doi.org\/10.1111\/jgs.14956","journal-title":"J Am Geriatr Soc"},{"key":"2036_CR14","unstructured":"Yu Sisi L, Zheng L, Miaomiao (2019) etc. Meta-analysis of the association between Proton-pump inhibitor and the risk of dementia or Alzheimer disease [ J ]. Chinese general practice, 22(23): 2861\u20132865"},{"issue":"6","key":"2036_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s40264-018-0638-2","volume":"41","author":"SK Park","year":"2018","unstructured":"Park SK, Baek YH, Pratt N, Kalisch Ellett L, Shin JY (2018) The uncertainty of the association between proton pump inhibitor use and the risk of dementia: prescription sequence symmetry analysis using a Korean healthcare database between 2002 and 2013. Drug Saf 41(6):615\u2013624. https:\/\/doi.org\/10.1007\/s40264-018-0638-2","journal-title":"Drug Saf"},{"issue":"12","key":"2036_CR16","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/ajg.2017.196","volume":"112","author":"H Taipale","year":"2017","unstructured":"Taipale H, Tolppanen AM, Tiihonen M, Tanskanen A, Tiihonen J, Hartikainen S (2017) No association between proton pump inhibitor use and risk of alzheimer\u2019s disease. Am J Gastroenterol 112(12):1802\u20131808. https:\/\/doi.org\/10.1038\/ajg.2017.196","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"2036_CR17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1053\/j.gastro.2017.06.061","volume":"153","author":"P Lochhead","year":"2017","unstructured":"Lochhead P, Hagan K, Joshi AD et al (2017) Association between proton pump inhibitor use and cognitive function in women. Gastroenterology 153(4):971\u2013979e4. https:\/\/doi.org\/10.1053\/j.gastro.2017.06.061","journal-title":"Gastroenterology"},{"issue":"11","key":"2036_CR18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.jagp.2018.06.002","volume":"26","author":"IC Hwang","year":"2018","unstructured":"Hwang IC, Chang J, Park SM (2018) A nationwide Population-Based cohort study of dementia risk among acid suppressant users. Am J Geriatr Psychiatry 26(11):1175\u20131183. https:\/\/doi.org\/10.1016\/j.jagp.2018.06.002","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"2036_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/jgs.15073","volume":"66","author":"SL Gray","year":"2018","unstructured":"Gray SL, Walker RL, Dublin S et al (2018) Proton pump inhibitor use and dementia risk: prospective Population-Based study. J Am Geriatr Soc 66(2):247\u2013253. https:\/\/doi.org\/10.1111\/jgs.15073","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"2036_CR20","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s40264-018-0704-9","volume":"41","author":"P Imfeld","year":"2018","unstructured":"Imfeld P, Bodmer M, Jick SS, Meier CR (2018) Proton pump inhibitor use and risk of developing alzheimer\u2019s disease or vascular dementia: A Case-Control analysis. Drug Saf 41(12):1387\u20131396. https:\/\/doi.org\/10.1007\/s40264-018-0704-9","journal-title":"Drug Saf"},{"issue":"3","key":"2036_CR21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1053\/j.gastro.2019.10.023","volume":"158","author":"C Ma","year":"2020","unstructured":"Ma C, Shaheen AA, Congly SE, Andrews CN, Moayyedi P, Forbes N (2020) Interpreting reported risks associated with use of proton pump inhibitors: residual confounding in a 10-Year analysis of National ambulatory data. Gastroenterology 158(3):780\u2013782e3. https:\/\/doi.org\/10.1053\/j.gastro.2019.10.023","journal-title":"Gastroenterology"},{"issue":"7","key":"2036_CR22","doi-asserted-by":"publisher","first-page":"e14422","DOI":"10.1097\/MD.0000000000014422","volume":"98","author":"M Li","year":"2019","unstructured":"Li M, Luo Z, Yu S, Tang Z (2019) Proton pump inhibitor use and risk of dementia: systematic review and meta-analysis. Med (Baltim) 98(7):e14422. https:\/\/doi.org\/10.1097\/MD.0000000000014422","journal-title":"Med (Baltim)"},{"issue":"7","key":"2036_CR23","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1017\/S1041610215002082","volume":"28","author":"A Booker","year":"2016","unstructured":"Booker A, Jacob LE, Rapp M, Bohlken J, Kostev K (2016) Risk factors for dementia diagnosis in German primary care practices. Int Psychogeriatr 28(7):1059\u20131065. https:\/\/doi.org\/10.1017\/S1041610215002082","journal-title":"Int Psychogeriatr"},{"issue":"9","key":"2036_CR24","doi-asserted-by":"publisher","first-page":"e0237676","DOI":"10.1371\/journal.pone.0237676","volume":"15","author":"R Cooksey","year":"2020","unstructured":"Cooksey R, Kennedy J, Dennis MS et al (2020) Proton pump inhibitors and dementia risk: evidence from a cohort study using linked routinely collected National health data in wales, UK. PLoS ONE 15(9):e0237676 Published 2020 Sep 18. https:\/\/doi.org\/10.1371\/journal.pone.0237676","journal-title":"PLoS ONE"},{"issue":"1","key":"2036_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/ije\/dyh016","volume":"33","author":"MD Tobin","year":"2004","unstructured":"Tobin MD, Minelli C, Burton PR, Thompson JR (2004) Commentary: development of Mendelian randomization: from hypothesis test to \u2018mendelian deconfounding\u2019. Int J Epidemiol 33(1):26\u201329. https:\/\/doi.org\/10.1093\/ije\/dyh016","journal-title":"Int J Epidemiol"},{"issue":"5","key":"2036_CR26","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","volume":"26","author":"S Burgess","year":"2017","unstructured":"Burgess S, Small DS, Thompson SG (2017) A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res 26(5):2333\u20132355. https:\/\/doi.org\/10.1177\/0962280215597579","journal-title":"Stat Methods Med Res"},{"key":"2036_CR27","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362:k601 Published 2018 Jul 12. https:\/\/doi.org\/10.1136\/bmj.k601","journal-title":"BMJ"},{"issue":"6","key":"2036_CR28","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/ije\/dyw220","volume":"45","author":"J Bowden","year":"2016","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR (2016) Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol 45(6):1961\u20131974. https:\/\/doi.org\/10.1093\/ije\/dyw220","journal-title":"Int J Epidemiol"},{"issue":"7","key":"2036_CR29","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658\u2013665. https:\/\/doi.org\/10.1002\/gepi.21758","journal-title":"Genet Epidemiol"},{"issue":"12","key":"2036_CR30","doi-asserted-by":"publisher","first-page":"e1004141","DOI":"10.1371\/journal.pmed.1004141","volume":"19","author":"L Zagkos","year":"2022","unstructured":"Zagkos L, Dib MJ, Pinto R et al (2022) Associations of genetically predicted fatty acid levels across the phenome: A Mendelian randomisation study. PLoS Med 19(12):e1004141 Published 2022 Dec 29. https:\/\/doi.org\/10.1371\/journal.pmed.1004141","journal-title":"PLoS Med"},{"issue":"4","key":"2036_CR31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent Estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304\u2013314. https:\/\/doi.org\/10.1002\/gepi.21965","journal-title":"Genet Epidemiol"},{"issue":"2","key":"2036_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect Estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512\u2013525. https:\/\/doi.org\/10.1093\/ije\/dyv080","journal-title":"Int J Epidemiol"},{"issue":"11","key":"2036_CR33","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sim.6835","volume":"35","author":"S Burgess","year":"2016","unstructured":"Burgess S, Dudbridge F, Thompson SG (2016) Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med 35(11):1880\u20131906. https:\/\/doi.org\/10.1002\/sim.6835","journal-title":"Stat Med"},{"key":"2036_CR34","doi-asserted-by":"crossref","unstructured":"Nolte IM Metasubtract:an R-package to analytically produce leave-one-out meta-analysis GWAS summary statistics[J].Bioinformatics,2020,36(16):4521\u20134522","DOI":"10.1093\/bioinformatics\/btaa570"},{"issue":"11","key":"2036_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.33588\/rn.6611.2017519","volume":"66","author":"J Garre-Olmo","year":"2018","unstructured":"Garre-Olmo J (2018) Epidemiologia de La enfermedad de alzheimer y Otras demencias [Epidemiology of alzheimer\u2019s disease and other dementias]. Rev Neurol 66(11):377\u2013386","journal-title":"Rev Neurol"},{"key":"2036_CR36","doi-asserted-by":"publisher","unstructured":"Zhang P, Li Z, Chen P et al (2022) Regular proton pump inhibitor use and incident dementia: population-based cohort study. BMC Med.;20(1):271. Published 2022 Sep 1. https:\/\/doi.org\/10.1186\/s12916-022-02478-y","DOI":"10.1186\/s12916-022-02478-y"},{"key":"2036_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13195-015-0164-8","volume":"7","author":"S Akter","year":"2015","unstructured":"Akter S, Hassan MR, Shahriar M, Akter N, Abbas MG, Bhuiyan MA (2015) Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software. Alzheimers Res Ther 7:79 Published 2015 Dec 27. https:\/\/doi.org\/10.1186\/s13195-015-0164-8","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2036_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ana.20889","volume":"60","author":"HA Archer","year":"2006","unstructured":"Archer HA, Edison P, Brooks DJ et al (2006) Amyloid load and cerebral atrophy in alzheimer\u2019s disease: an 11\u00a0C-PIB positron emission tomography study. Ann Neurol 60(1):145\u2013147. https:\/\/doi.org\/10.1002\/ana.20889","journal-title":"Ann Neurol"},{"issue":"3","key":"2036_CR39","doi-asserted-by":"publisher","first-page":"e58837","DOI":"10.1371\/journal.pone.0058837","volume":"8","author":"N Badiola","year":"2013","unstructured":"Badiola N, Alcalde V, Pujol A et al (2013) The proton-pump inhibitor Lansoprazole enhances amyloid beta production. PLoS ONE 8(3):e58837. https:\/\/doi.org\/10.1371\/journal.pone.0058837","journal-title":"PLoS ONE"},{"issue":"4","key":"2036_CR40","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/cbdd.12555","volume":"86","author":"HS Kundaikar","year":"2015","unstructured":"Kundaikar HS, Degani MS (2015) Insights into the interaction mechanism of ligands with A\u03b242 based on molecular dynamics simulations and mechanics: implications of role of common binding site in drug design for alzheimer\u2019s disease. Chem Biol Drug Des 86(4):805\u2013812. https:\/\/doi.org\/10.1111\/cbdd.12555","journal-title":"Chem Biol Drug Des"},{"issue":"12","key":"2036_CR41","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1021\/acschemneuro.7b00230","volume":"8","author":"S Rafiee","year":"2017","unstructured":"Rafiee S, Asadollahi K, Riazi G, Ahmadian S, Saboury AA (2017) Vitamin B12 inhibits Tau fibrillization via binding to cysteine residues of Tau. ACS Chem Neurosci 8(12):2676\u20132682. https:\/\/doi.org\/10.1021\/acschemneuro.7b00230","journal-title":"ACS Chem Neurosci"},{"issue":"22","key":"2036_CR42","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1001\/jama.2013.280490","volume":"310","author":"JR Lam","year":"2013","unstructured":"Lam JR, Schneider JL, Zhao W, Corley DA (2013) Proton pump inhibitor and Histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 310(22):2435\u20132442. https:\/\/doi.org\/10.1001\/jama.2013.280490","journal-title":"JAMA"},{"issue":"7","key":"2036_CR43","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/nu9070725","volume":"9","author":"F Ma","year":"2017","unstructured":"Ma F, Wu T, Zhao J et al (2017) Plasma homocysteine and serum folate and vitamin B12 levels in mild cognitive impairment and alzheimer\u2019s disease: A Case-Control study. Nutrients 9(7):725 Published 2017 Jul 8. https:\/\/doi.org\/10.3390\/nu9070725","journal-title":"Nutrients"},{"issue":"7","key":"2036_CR44","doi-asserted-by":"publisher","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","volume":"2","author":"EM Mandelkow","year":"2012","unstructured":"Mandelkow EM, Mandelkow E (2012) Biochemistry and cell biology of Tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2(7):a006247. https:\/\/doi.org\/10.1101\/cshperspect.a006247","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10004","key":"2036_CR45","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","volume":"386","author":"J Bang","year":"2015","unstructured":"Bang J, Spina S, Miller BL (2015) Frontotemporal dementia. Lancet 386(10004):1672\u20131682. https:\/\/doi.org\/10.1016\/S0140-6736(15)00461-4","journal-title":"Lancet"},{"key":"2036_CR46","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3389\/fneur.2018.01142","volume":"9","author":"M Novotny","year":"2019","unstructured":"Novotny M, Klimova B, Valis M (2019) PPI long term use: risk of neurological adverse events?? Front Neurol 9:1142 Published 2019 Jan 8. https:\/\/doi.org\/10.3389\/fneur.2018.01142","journal-title":"Front Neurol"},{"key":"2036_CR47","doi-asserted-by":"publisher","first-page":"5257285","DOI":"10.1155\/2018\/5257285","volume":"2018","author":"G Ortiz-Guerrero","year":"2018","unstructured":"Ortiz-Guerrero G, Amador-Mu\u00f1oz D, Calder\u00f3n-Ospina CA, L\u00f3pez-Fuentes D, Nava Mesa MO (2018) Proton pump inhibitors and dementia: physiopathological mechanisms and clinical consequences. Neural Plast 2018:5257285. https:\/\/doi.org\/10.1155\/2018\/5257285. Published 2018 Mar 21","journal-title":"Neural Plast"},{"issue":"10004","key":"2036_CR48","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","volume":"386","author":"JT O\u2019Brien","year":"2015","unstructured":"O\u2019Brien JT, Thomas A (2015) Vascular dementia. Lancet 386(10004):1698\u20131706. https:\/\/doi.org\/10.1016\/S0140-6736(15)00463-8","journal-title":"Lancet"},{"issue":"8","key":"2036_CR49","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/ATVBAHA.119.311908","volume":"39","author":"FJ Wolters","year":"2019","unstructured":"Wolters FJ, Ikram MA (2019) Epidemiology of vascular dementia. Arterioscler Thromb Vasc Biol 39(8):1542\u20131549. https:\/\/doi.org\/10.1161\/ATVBAHA.119.311908","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2036_CR50","doi-asserted-by":"publisher","first-page":"e70487","DOI":"10.1371\/journal.pone.0070487","volume":"8","author":"RK Sodhi","year":"2013","unstructured":"Sodhi RK, Singh N (2013) Defensive effect of Lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet. PLoS ONE 8(7):e70487 Published 2013 Jul 31. https:\/\/doi.org\/10.1371\/journal.pone.0070487","journal-title":"PLoS ONE"},{"issue":"5","key":"2036_CR51","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/glia.21157","volume":"59","author":"S Hashioka","year":"2011","unstructured":"Hashioka S, Klegeris A, McGeer PL (2011) Proton pump inhibitors reduce interferon-\u03b3-induced neurotoxicity and STAT3 phosphorylation of human astrocytes. Glia 59(5):833\u2013840. https:\/\/doi.org\/10.1002\/glia.21157","journal-title":"Glia"},{"issue":"1","key":"2036_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.expneurol.2009.02.002","volume":"217","author":"S Hashioka","year":"2009","unstructured":"Hashioka S, Klegeris A, McGeer PL (2009) Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity. Exp Neurol 217(1):177\u2013183. https:\/\/doi.org\/10.1016\/j.expneurol.2009.02.002","journal-title":"Exp Neurol"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-02036-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-025-02036-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-02036-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:13:09Z","timestamp":1763701989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-025-02036-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2036"],"URL":"https:\/\/doi.org\/10.1007\/s00406-025-02036-6","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"20 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}